U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
1854118541Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure StudyRecruitingNo Results AvailableHypertensionBehavioral: BP measurement & pharmacy|Behavioral: BP educational materialshttps://ClinicalTrials.gov/show/NCT02321618
1854218542Efficacy of Best Possible Self Intervention Over TimeCompletedNo Results AvailableBest Possible Self InterventionBehavioral: e-BPS|Behavioral: Daily Activitieshttps://ClinicalTrials.gov/show/NCT02321605
1854318543GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin LymphomaRecruitingNo Results AvailableHodgkin LymphomaDrug: AFM13https://ClinicalTrials.gov/show/NCT02321592
1854418544Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant CapacitiesRecruitingNo Results AvailableLiver Cirrhosis|Liver CancerDietary Supplement: vitamin B-6|Dietary Supplement: Glutathione|Dietary Supplement: Dextrinshttps://ClinicalTrials.gov/show/NCT02321579
1854518545Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.RecruitingNo Results AvailableTrigeminal Neuralgia (Burchiel Type I)|Trigeminal Neuralgia (Burchiel Type II)|Trigeminal Neuropathic Pain|Trigeminal Deafferentation Pain|Complex Regional Pain Syndrome (Types I and II, Involving the Upper Extremity)|Glossopharyngeal Neuralgia|Upper ExtrDevice: Epidural Motor Cortex Stimulationhttps://ClinicalTrials.gov/show/NCT02321566
1854618546Effect of Brown Rice on the Risk Factors for Metabolic SyndromeCompletedNo Results AvailableMetabolic SyndromeOther: Brown rice|Other: White ricehttps://ClinicalTrials.gov/show/NCT02321553
1854718547A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung CancerRecruitingNo Results AvailableLung CancerDrug: Ibrutinibhttps://ClinicalTrials.gov/show/NCT02321540
1854818548Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer PatientsRecruitingNo Results AvailableBreast CancerDrug: Perflutren Protein-Type A Microspheres Injectable Suspension|Device: Contrast-Enhanced Ultrasound (CEUS)|Procedure: Biopsy + Radioactive Seed Placement|Behavioral: Phone Callhttps://ClinicalTrials.gov/show/NCT02321527
1854918549Early Feasibility Study of the Tendyne Mitral Valve SystemRecruitingNo Results AvailableMitral Valve RegurgitationDevice: Tendyne Mitral Valve Systemhttps://ClinicalTrials.gov/show/NCT02321514
1855018550Phase I/Ib Dose Escalation & Biomarker Study of Ceritinib (LDK378) + Everolimus for Locally Advanced or Metastatic Solid Tumors With an Expansion in Non-Small Cell Lung Cancer (NSCLC) Characterized by Abnormalities in Anaplastic Lymphoma Kinase (ALK) ExprNot yet recruitingNo Results AvailableHead and Neck Cancer|Lung CancerDrug: Ceritinib (LDK378)|Drug: Ceritinib (LDK378) 750 mg|Drug: Everolimushttps://ClinicalTrials.gov/show/NCT02321501
1855118551Patient Centered Outcomes Research Institute (PCORI) Provider Survey on Treatment EligibilityRecruitingNo Results AvailableColorectal CancerBehavioral: Surveyhttps://ClinicalTrials.gov/show/NCT02321488
1855218552EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive DisordersCompletedNo Results AvailableCognitive DisordersDrug: EGb761®https://ClinicalTrials.gov/show/NCT02321475
1855318553Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing ColonoscopyRecruitingNo Results AvailableBowel CleansingDrug: Eziclen|Drug: Fortrans®https://ClinicalTrials.gov/show/NCT02321462
1855418554The Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or OverCompletedNo Results AvailableInsomniahttps://ClinicalTrials.gov/show/NCT02321449
1855518555Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity ProgressionRecruitingNo Results AvailableStroke|Upper Limb SpasticityDrug: AbobotulinumtoxinA|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02321436
1855618556International Pachyonychia Congenita Research RegistryRecruitingNo Results AvailablePachyonychia Congenitahttps://ClinicalTrials.gov/show/NCT02321423
1855718557"In Vivo" Comparison in Human Carotid Atherosclerosis: Plaque NeovascularizationRecruitingNo Results AvailableCarotid Artery Disease|Plaque NeovascularizationOther: Contrast enhanced ultrasound of the carotid plaque|Other: Dynamic contrast-enhanced carotid plaque MRIhttps://ClinicalTrials.gov/show/NCT02321410
1855818558To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer PainRecruitingNo Results AvailableMalignant Pain|Non-malignant PainDrug: Oxycodone|Drug: Naloxonehttps://ClinicalTrials.gov/show/NCT02321397
1855918559A Study in Healthy Volunteers to Investigate the Safety, Tolerability, and Pharmacokinetics of RO6889678, Food Effects of Single-Dose RO6889678, and the Effect of Multiple Dosing of RO6889678 on the Pharmacokinetics of MidazolamRecruitingNo Results AvailableHealthy VolunteerDrug: Placebo|Drug: RO6889678|Drug: midazolamhttps://ClinicalTrials.gov/show/NCT02321384
1856018560Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.RecruitingNo Results AvailableAcute on Chronic Liver Failure With Hepatic Encephalopathy.Drug: Lactulose + Rifaximin|Drug: Lactulosehttps://ClinicalTrials.gov/show/NCT02321371
1856118561Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer SurvivorsRecruitingNo Results AvailableQuality of Life|Physical Activity|Fatigue|Breast Cancer|Prostate CancerBehavioral: Two-time implementation intention|Behavioral: One-time implementation intention|Behavioral: Sham Comparator|Behavioral: Physical Activity Materialshttps://ClinicalTrials.gov/show/NCT02321358
1856218562Pre-Transplant Evaluation by Supportive Care Team for Patients Undergoing HCT for Hematological MalignanciesRecruitingNo Results AvailableMalignancies, HematologicOther: Palliative Care Supporthttps://ClinicalTrials.gov/show/NCT02321345
1856318563Unilateral Sequential Sympathectomy for Palmar HyperhidrosisCompletedNo Results AvailablePalmar HyperhidrosisProcedure: bilateral simultaneous endoscopic thoracic symapthectomy|Procedure: unilateral sequential endoscopic thoracic symapthectomy.https://ClinicalTrials.gov/show/NCT02321332
1856418564Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain PatientsRecruitingNo Results AvailableChronic PainDrug: Hydromorphone HCl ER Tabletshttps://ClinicalTrials.gov/show/NCT02321319
1856518565An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary CirrhosisWithdrawnNo Results AvailablePrimary Biliary CirrhosisDrug: LUM001https://ClinicalTrials.gov/show/NCT02321306
1856618566A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLCRecruitingNo Results AvailableLung CancerDietary Supplement: CurcuVIVAâ„¢|Drug: Tyrosine Kinase Inhibitor gefitinib (Iressa)|Drug: Tyrosine Kinase Inhibitor erlotinib (Tarceva)https://ClinicalTrials.gov/show/NCT02321293
1856718567The Efficacy of Denosumab in Active Crohn's DiseaseNot yet recruitingNo Results AvailableCrohn DiseaseDrug: Denosumabhttps://ClinicalTrials.gov/show/NCT02321280
1856818568Cohort Study of the Clinical Course of Macular Diseases in KagawaRecruitingNo Results AvailableMacular DiseaseDrug: ranibizumab, aflibercept, pegaptanib, verteporphinhttps://ClinicalTrials.gov/show/NCT02321267
1856918569Myoelectric Robot-assisted Rehabilitation for the Upper Limb After StrokeRecruitingNo Results AvailableStrokeDevice: The RehaARM-Robot|Behavioral: Standard rehabilitation therapyhttps://ClinicalTrials.gov/show/NCT02321254
1857018570Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMDNot yet recruitingNo Results AvailableWet Macular DegenerationDrug: Aflibercept (EYLEA, BAY-86-5321)https://ClinicalTrials.gov/show/NCT02321241

* Görseller ve İçerik tekif hakkına sahip olabilir